Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2000
05/18/2000WO2000027367A1 A capsule based drug delivery system
05/18/2000WO2000027366A1 Pharmaceutical formulation comprising omeprazole
05/18/2000WO2000027365A1 Functionalized nanocrystals and their use in detection systems
05/18/2000WO2000027364A1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it
05/18/2000WO2000027363A1 Aerosols comprising nanoparticle drugs
05/18/2000WO2000027362A1 Method of producing vitamin powders
05/18/2000WO2000027361A1 Stabilized nucleic acid compositions and methods of preparation and use thereof
05/18/2000WO2000027360A1 Treatment set containing lungsurfactant compositions
05/18/2000WO2000027359A1 An inhalation system
05/18/2000WO2000027358A2 Aqueous composition containing two acid-functional vinyl polymers
05/18/2000WO2000027357A1 Improved fast disintegrating tablet
05/18/2000WO2000027207A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
05/18/2000WO2000027204A1 Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type
05/18/2000WO2000027191A1 Disposable premoistened wipe containing an antimicrobial protease inhibitor
05/18/2000WO2000009672A9 Dnazymes and methods for treating restenosis
05/18/2000WO2000009097A3 Pharmaceutical composition with antitumor activity on the basis of carboplatin
05/18/2000WO2000007979A3 Compounds and compositions for delivering active agents
05/18/2000WO2000000186A9 Method of treating topical ailments
05/18/2000WO1999066978A9 Method, implant and delivery system for enhancing blood flow in tissue
05/18/2000DE19945814A1 Verfahren zur Zubereitung eines pharmazeutischen Artemisia-Extraktes und Vorrichtung zur elektrischen Moxibustion unter Verwendung des Extraktes A process for the preparation of a pharmaceutical Artemisia extract and moxibustion device for electrically using the extract
05/18/2000DE19852826A1 Poly(alpha-1,4-D-Glucan) Poly (alpha-1,4-D-glucan)
05/18/2000DE19852245A1 5-Aminolävulinsäure-Nanoemulsion 5-aminolevulinic acid nanoemulsions
05/18/2000DE19848260A1 Fumarsäure-Mikrotabletten Fumaric microtablets
05/18/2000CA2704598A1 Methods of purifying recombinant human erythropoietin from cell culture supernatants
05/18/2000CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine
05/18/2000CA2350667A1 Cross-linked hyaluronic acids and medical uses thereof
05/18/2000CA2350304A1 Dispersible compositions containing l-dopa ethyl ester
05/18/2000CA2349947A1 Method of producing vitamin powders
05/18/2000CA2349859A1 Stabilized nucleic acid compositions and methods of preparation and use thereof
05/18/2000CA2349700A1 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
05/18/2000CA2349445A1 Antisense oligomer
05/18/2000CA2348900A1 Disposable premoistened wipe containing an antimicrobial protease inhibitor
05/18/2000CA2348843A1 A capsule based drug delivery system
05/18/2000CA2347978A1 Method of depositing a dry powder and dispensing device
05/18/2000CA2345620A1 Products and methods for brachytherapy
05/18/2000CA2318162A1 Oxy-vanadium (iv) complexes having spermicidal activity
05/17/2000EP1000627A1 Aqueous preparation of lactoferrin having improved stability
05/17/2000EP1000618A1 Topical capsaicin preparation
05/17/2000EP1000617A2 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
05/17/2000EP1000616A1 Prevention and treatment of parodontitis
05/17/2000EP1000615A2 Preparation of pharmaceutically active particles
05/17/2000EP1000614A1 Sucralfate-containing composition and process for the preparation thereof
05/17/2000EP1000541A1 Defined serumfree medical solution for ophthalmology
05/17/2000EP1000079A1 New formulation
05/17/2000EP0999855A1 Polymer based pharmaceutical compositions for targeted delivery of biologically active agents
05/17/2000EP0999854A1 Switchable viscoelastic systems containing galactomannan polymers and borate
05/17/2000EP0999843A1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
05/17/2000EP0999841A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
05/17/2000EP0999839A1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
05/17/2000EP0999838A1 Self-emulsifying formulation for lipophilic compounds
05/17/2000EP0999833A1 Taxol emulsion
05/17/2000EP0999831A1 Use of petroselinum acid for treating inflammations
05/17/2000EP0999830A1 Sertraline salts and sustained-release dosage forms of sertraline
05/17/2000EP0999829A1 Solubilized sertraline compositions
05/17/2000EP0999828A2 Method for producing active agent preparations with controlled release from a matrix
05/17/2000EP0999827A1 Novel liposome vectors of active principles
05/17/2000EP0999826A1 Self-emulsifying formulation for lipophilic compounds
05/17/2000EP0999825A1 Ophthalmic compositions containing galactomannan polymers and borate
05/17/2000EP0999824A1 Release devices
05/17/2000EP0871437B1 Use of boswellic acid for treating brain tumours
05/17/2000EP0804191B1 Use of inhibitors of platelet derived growth receptor for the manufacture of a medicament for the treatment of cancers
05/17/2000EP0796238B1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics
05/17/2000EP0796085B1 Solubilisation aids for hydrophilic macromolecules
05/17/2000EP0776202B1 Liposome-encapsulated taxol, its preparation and its use
05/17/2000EP0731706B1 Use of dimeticone for the manufacture of a medicament for treating aphthae and stomatitis
05/17/2000EP0689426B1 Therapeutic agent for the treatment of melanomas
05/17/2000EP0605700B1 Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
05/17/2000EP0553272B1 Synthetic lung surfactant
05/17/2000CN1253560A Sulfonamides for treatment of endothelin-mediated disorders
05/17/2000CN1253544A Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate
05/17/2000CN1253509A Method of delivering halotherapy
05/17/2000CN1253508A Topical nasal antiinflammatory compositions
05/17/2000CN1253505A Pourable alginate compositions
05/17/2000CN1253503A Stabilized tibolone compositions
05/17/2000CN1253497A Swallow tablet comprising paracetamol
05/17/2000CN1253032A Microcapsule containing core material and its producing method
05/17/2000CN1253022A Composition used to enhance permeability of skin medicament
05/17/2000CN1253018A Nm-class insulin particles and their preparing process
05/17/2000CN1253011A Chinese medicine for treating myasthenia and its preparing process
05/17/2000CN1253010A Exterior-applied Chinese-medicinal ointment for treating piles
05/17/2000CN1253009A Antalgic liquid for eliminating obstruction of vital energy and blood flow
05/17/2000CN1253002A Anti-cold oral liquid and its preparing process
05/17/2000CN1252995A Burn cream
05/17/2000CN1252994A Mercury chloride injection
05/17/2000CN1252992A Carboprost methylate preparation able to be absorbed via oral mucosa and its preparing process
05/17/2000CN1052425C Process for preparing articles for acute bronchitis
05/17/2000CN1052418C Antalgic paster and its preparation method
05/17/2000CN1052416C Medicine bag for treatment of indigestion and child digestive disorder and its preparing process
05/17/2000CN1052413C Yinhuang Ganfu powder for curing hepatitis and its preparing process
05/17/2000CN1052404C Snakehead oral liquid
05/17/2000CN1052401C Medicaments
05/17/2000CN1052399C Smell covered-up medicine composition
05/17/2000CN1052398C Pharmaceutical spheroid formulation
05/17/2000CN1052397C Method for preparing pharmaceutical beadlets
05/16/2000US6064313 Alternating current circuit and outlet tester
05/16/2000US6063927 Paroxetine derivatives
05/16/2000US6063915 Carrageenan compositions and methods for their production
05/16/2000US6063910 Bringing droplets of liquid protein solution in a solvent into contact at controlled rate with excess of supercritical antisolvent which dissolves and expands liquid solution and precipitates dry protein particles; for time-release drugs
05/16/2000US6063909 Preparation of factor IX
05/16/2000US6063821 Antiinflammatory agents and extrusion for administering and antipyretics
1 ... 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 ... 2991